These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 9830274
1. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics. Jan IS, Hsueh PR, Teng LJ, Ho SW, Luh KT. J Formos Med Assoc; 1998 Oct; 97(10):661-6. PubMed ID: 9830274 [Abstract] [Full Text] [Related]
2. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S. Med Sci Monit; 2006 Nov; 12(11):BR362-5. PubMed ID: 17072265 [Abstract] [Full Text] [Related]
3. Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases. Manchanda V, Singh NP, Goyal R, Kumar A, Thukral SS. Indian J Med Res; 2005 Oct; 122(4):330-7. PubMed ID: 16394326 [Abstract] [Full Text] [Related]
4. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group. J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502 [Abstract] [Full Text] [Related]
5. Occurrence of extended-spectrum beta-lactamase in clinical isolates of Klebsiella pneumoniae in a University Hospital, Thailand. Kusum M, Wongwanich S, Dhiraputra C, Pongpech P, Naenna P. J Med Assoc Thai; 2004 Sep; 87(9):1029-33. PubMed ID: 15516002 [Abstract] [Full Text] [Related]
7. [Effect of inoculum size on sensitivity and specificity of the double-disk synergy test for the detection of wide-spectrum beta-lactamases]. Bedenić B, Boras A. Lijec Vjesn; 2001 Sep; 123(11-12):293-6. PubMed ID: 11930754 [Abstract] [Full Text] [Related]
10. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases. Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH. J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086 [Abstract] [Full Text] [Related]
11. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center. Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S. P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176 [Abstract] [Full Text] [Related]
14. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Procop GW, Tuohy MJ, Wilson DA, Williams D, Hadziyannis E, Hall GS. Am J Clin Pathol; 2003 Aug; 120(2):265-7. PubMed ID: 12931557 [Abstract] [Full Text] [Related]
15. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z. Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461 [Abstract] [Full Text] [Related]